FRIDAY, JULY 31, 2026 6:05:07 PM
My Quest A/c
Online Trading
Employee Email
(A)+
(A)
(A)-
Skip to main content
Equity
|
Currency
|
Mutual Fund
|
IPO
|
Financial Tools
|
e-Voting
Home
|
About Us
|
Product and Services
Equity
Derivatives
Commodities
Mutual Fund
IPO
Currency
Depository
|
Corporate Consultancy
|
Empowered Investor
|
Download
|
Career
|
Contact Us
Mission
Vision
Board of Directors
Memberships
Why Quest
Commodity
Currency
Equity and Derivatives
Quest News
Equity
Derivatives
Commodities
Mutual Fund
IPO
Currency
Depository
SEARCH
Quotes
News
NAV
Daily Market Tracker
Gainers & Losers
Advances & Declines
Value & Volume Toppers
Live Indices
Index Movers
Buyers & Sellers
Bulk Deals
Block Deals
Sector Watch
Market Analysis
New Highs & Lows
52 Week Highs & Lows
Exchange Holidays
Index Constituents
Unusual Volume
Out & Under Performers
Historical Returns
Stock Screener
Company Profile
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
Price Chart
Beta Analysis
Deliverable Volumes
Technical Chart
Corporate Actions
BSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Names
Split Of Face Value
Merger & Demerger
Other Markets
ADR Prices
GDR Prices
World Indices
FII Activities
DII Activities
Forex Details
News
Pre-Session
Mid-Session
End-Session
Quick Review
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Currency News
Market Commentary
Mutual Fund News
Commodity News
Corporate Results
Business News
Balance Sheet
Markets > Corporate Information > Balance Sheet
Albert David Ltd
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value
(
R
)
NSE
Symbol
Div Yield
%
Market Cap
(
R
s
.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(
R
)
524075
INE155C01010
685.7077058
ALBERTDAVD
0.73
391.22
0
0
10
Your Result on : Markets | Equity | Corporate Information | Balance Sheet
Particulars
Mar 2026
(
R
s
.Cr)
Mar 2025
(
R
s
.Cr)
Mar 2024
(
R
s
.Cr)
Mar 2023
(
R
s
.Cr)
Mar 2022
(
R
s
.Cr)
Mar 2021
(
R
s
.Cr)
SOURCES OF FUNDS :
Share Capital
5.71
5.71
5.71
5.71
5.71
5.71
Reserves Total
385.83
386.78
377.27
305.87
273.76
238.67
Equity Share Warrants
0.00
0.00
0.00
0.00
0.00
0.00
Equity Application Money
0.00
0.00
0.00
0.00
0.00
0.00
Total Shareholders Funds
391.54
392.49
382.98
311.58
279.47
244.38
Secured Loans
28.48
10.05
2.10
3.97
3.77
0.43
Unsecured Loans
1.10
2.27
1.22
1.35
1.90
1.19
Total Debt
29.58
12.32
3.32
5.32
5.67
1.62
Other Liabilities
6.74
7.10
12.08
12.26
12.92
15.04
Total Liabilities
427.86
411.91
398.38
329.16
298.06
261.04
APPLICATION OF FUNDS :
Gross Block
261.70
253.40
232.72
223.88
223.87
212.17
Less : Accumulated Depreciation
162.05
154.62
149.33
143.85
136.19
128.21
Less:Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
99.65
98.78
83.39
80.03
87.68
83.96
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
20.77
1.92
6.74
2.72
0.81
0.75
Producing Properties
0.00
0.00
0.00
0.00
0.00
0.00
Investments
243.29
260.16
273.14
192.66
183.09
137.68
Current Assets, Loans & Advances
Inventories
58.27
63.90
43.61
50.68
39.18
35.75
Sundry Debtors
33.92
27.37
29.33
30.33
25.00
19.49
Cash and Bank Balance
32.77
1.69
31.16
25.22
18.56
35.37
Loans and Advances
24.39
18.86
13.23
31.23
14.10
18.54
Total Current Assets
149.35
111.83
117.34
137.46
96.85
109.14
Less : Current Liabilities and Provisions
Current Liabilities
68.01
72.58
75.75
74.66
78.69
58.15
Provisions
18.19
20.61
20.57
19.58
24.10
21.21
Total Current Liabilities & Provisions
86.20
93.19
96.33
94.24
102.78
79.37
Net Current Assets
63.15
18.64
21.01
43.22
-5.94
29.77
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets
3.93
4.25
5.08
4.95
4.69
4.46
Deferred Tax Liability
9.01
10.57
8.36
3.97
5.09
5.43
Net Deferred Tax
-5.08
-6.32
-3.28
0.98
-0.40
-0.97
Other Assets
6.08
38.71
17.39
9.55
32.81
9.84
Total Assets
427.86
411.89
398.39
329.15
298.05
261.03
Contingent Liabilities
4.68
4.62
4.52
1.96
1.63
4.03